An increasing number of European countries have detected gonococcal strains resistant to the antibiotic ceftriaxone, the first-line drug to treat gonorrhoea infection. Alongside growing evidence of the domestic spread of such resistant strains in Europe over the last two years, this poses a significant challenge for future treatment options for one of the most common sexually transmitted diseases worldwide, according to an assessment issued by the European Centre for Disease Prevention and Control (ECDC) today…
Source: European Centre for Disease Prevention and Control (ECDC)
European Centre for Disease Prevention and Control (ECDC)
- Ebola disease outbreak in the Democratic Republic of the Congo and Uganda
- World Mosquito Day 2026: Europe must upgrade control tools as disease risks rise
- Epidemiological update – 11 August 2026: Imported case of Andes hantavirus in the EU/EEA
- Surveillance of Mpox in the EU/EEA, monthly report
- Chikungunya virus disease worldwide overview
- As sustained heatwaves increase the risk of infectious diseases across Europe, ECDC scales up action and calls for cooperation
- World Hepatitis Day 2026: Ensuring that life-saving interventions are accessible to everyone who needs them is a common challenge
- World Hepatitis Day 2026: Despite progress towards eliminating hepatitis in Europe, gaps in prevention measures keep 2030 targets out of reach
- New guidance launched to help Europe detect respiratory virus threats earlier
- Drug-resistant gonorrhoea on the rise in Europe, ECDC warns
